Debate on "dual pathway inhibition": Antiplatelet therapy in patients with peripheral atherosclerotic disease: old but gold?

被引:1
|
作者
Spaccarotella, Carmen [1 ]
Simonetti, Fiorenzo [1 ]
Piccolo, Raffaele [1 ]
Esposito, Giovanni [1 ]
机构
[1] Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Via Pansini 5, I-80131 Naples, Italy
关键词
ANKLE BRACHIAL INDEX; CARDIOVASCULAR EVENTS; ARTERY-DISEASE; RISK; PREVENTION; ASPIRIN; CLOPIDOGREL; MORTALITY;
D O I
10.1714/4035.40103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:24S / 27S
页数:4
相关论文
共 50 条
  • [41] Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease
    Nicolajsen, Chalotte W.
    Sogaard, Mette
    Jensen, Martin
    Eldrup, Nikolaj
    Larsen, Torben B.
    Goldhaber, Samuel Z.
    Behrendt, Christian-Alexander
    Nielsen, Peter B.
    JAMA NETWORK OPEN, 2023, 6 (10)
  • [42] Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive review
    Parascandolo, Eliot
    Eisen, Alon
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (09) : 577 - 585
  • [43] Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy
    Gremmel, Thomas
    Steiner, Sabine
    Seidinger, Daniela
    Koppensteiner, Renate
    Panzer, Simon
    Kopp, Christoph W.
    THROMBOSIS RESEARCH, 2009, 124 (05) : 588 - 591
  • [44] Response to Dual Antiplatelet Therapy in Patients with Peripheral Artery Occlusive Disease Suffering from Critical Limb Ischemia
    Wand, Saskia
    Baro, Daniel
    Baecker, Christina
    Meybohm, Patrick
    Schmitz-Rixen, Thomas
    Zacharowski, Kai
    Mutlak, Haitham
    Weber, Christian Friedrich
    CLINICAL LABORATORY, 2014, 60 (10) : 1601 - 1607
  • [45] Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis
    Navarese, Eliano P.
    Wernly, Bernhard
    Lichtenauer, Michael
    Petrescu, Aniela M.
    Kolodziejczak, Michalina
    Lauten, Alexander
    Frediani, Lara
    Veulemanns, Verena
    Wanha, Wojciech
    Wojakowski, Wojciech
    Lesiak, Maciej
    Ferrante, Giuseppe
    Zeus, Tobias
    Tantry, Udaya
    Bliden, Kevin
    Buffon, Antonino
    Contegiacomo, Gaetano
    Jung, Christian
    Kubica, Jacek
    Pestrichella, Vincenzo
    Gurbel, Paul A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 269 : 292 - 297
  • [46] Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients
    Robaux, Valentine
    Kautbally, Shakeel
    Ginion, Audrey
    Dechamps, Melanie
    Lejeune, Sibille
    Menghoum, Nassiba
    Bertrand, Luc
    Pouleur, Anne-Catherine
    Horman, Sandrine
    Beauloye, Christophe
    PLATELETS, 2023, 34 (01)
  • [47] Rationale and Design of Dual Antiplatelet Therapy in Patients with Coronary Multi-Vessel Disease (DAPT-MVD): A Multicenter, Randomized, Controlled Trial
    Tian, Jinwei
    Wang, Zhuozhong
    Wang, Yan
    Wang, Fan
    Wang, Yini
    Zhao, Peng
    Hou, Xinyu
    Peng, Xiang
    Tian, Maoyi
    Wang, Duolao
    Yu, Bo
    CLINICAL CARDIOLOGY, 2024, 47 (12)
  • [48] Antithrombotic therapy in patients with established atherosclerotic coronary disease
    Landi, Antonio
    Valgimigli, Marco
    HEART, 2023, 109 (13) : 1034 - 1043
  • [49] Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk
    Espinoza, Clifton
    Mukherjee, Debabrata
    HEART INTERNATIONAL, 2021, 15 (01): : 26 - 36
  • [50] Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
    Park, Byung Joon
    Hou, Linle
    Galmer, Andrew
    Johnston-Cox, Hillary
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2023, 25 (09) : 379 - 390